Cyclosporine Adverse Outcomes in Steroid Dependent and Frequent Relapsing Nephrotic Syndrome in Children;Single Center Study
Condition(s):Steroid Dependent and Frequent Relapsing Nephrotic SyndromeLast Updated:October 20, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Steroid Dependent and Frequent Relapsing Nephrotic SyndromeLast Updated:October 20, 2022Not yet recruiting
Condition(s):Autoimmune Hepatitis; Autoimmune Liver DiseaseLast Updated:July 10, 2023Recruiting
Condition(s):Nephrotic Syndrome Steroid-Dependent; Interleukin 2Last Updated:May 30, 2018Withdrawn
Condition(s):Safety and EfficacyLast Updated:December 1, 2021Recruiting
Condition(s):Nephrotic Syndrome Steroid-DependentLast Updated:December 21, 2022Recruiting
Condition(s):Steroid-Dependent Nephrotic SyndromeLast Updated:April 7, 2022Active, not recruiting
Condition(s):Steroid-Dependent Nephrotic SyndromeLast Updated:October 4, 2021Suspended
Condition(s):Nephrotic Syndrome Steroid-DependentLast Updated:September 14, 2020Terminated
Condition(s):Steroid-Dependent Nephrotic Syndrome; Steroid-Sensitive Nephrotic SyndromeLast Updated:November 9, 2023Recruiting
Condition(s):Nephrotic Syndrome in Children; TelitaciceptLast Updated:November 9, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.